Risk factors for mortality in patients with mucormycosis

By Spellberg Brad   Kontoyiannis Dimitrios P.   Fredricks David   Morris Michele I.   Perfect John R.   Chin-Hong Peter V.   Ibrahim Ashraf S.   Brass Eric P.  

Medical Mycology, Vol. 50, Iss. 6, 2012-08 ,pp. : 611-618

Informa Healthcare

Access to resources Recommend Favorite

Taxonomy and epidemiology of Mucor irregularis , agent of chronic cutaneous mucormycosis

By Lu X.-L.   Najafzadeh M.J.   Dolatabadi S.   Ran Y.-P.   Gerrits van den Ende A.H.G.   Shen Y.-N.   Li C.-Y.   Xi L.-Y.   Hao F.   Zhang Q.-Q.   Li R.-Y.   Hu Z.-M.   Lu G.-X.   Wang J.-J.   Drogari-Apiranthitou M.   Klaassen C.   Meis J.F.   Hagen F.   Liu W.-D.   de Hoog G.S.  

Persoonia - Molecular Phylogeny and Evolution of Fungi, Vol. 30, Iss. 1, 2013-06 ,pp. : 48-56

Nationaal Herbarium Nederland

Access to resources Recommend Favorite

Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?

By Ibrahim Ashraf   Edwards John   Bryant Richard   Spellberg Brad  

Medical Mycology, Vol. 47, Iss. 6, 2009-08 ,pp. : 592-600

Informa Healthcare

Access to resources Recommend Favorite

Palatal mucormycosis in patients with hematologic malignancy and stem cell transplantation

By Akhrass Fadi Al   Debiane Labib   Abdallah Lina   Best Leyla   Mulanovich Victor   Rolston Kenneth   Kontoyiannis Dimitrios P.  

Medical Mycology, Vol. 49, Iss. 4, 2011-05 ,pp. : 400-405

Informa Healthcare

Access to resources Recommend Favorite

Leghaemoglobin oxygenation gradients in alfalfa and yellow sweetclover nodules

By Denison R.F.  

Journal of Experimental Botany, Vol. 54, Iss. 384, 2003-03 ,pp. : 1085-1091

Oxford University Press

Access to resources Recommend Favorite